The Prevalence and Risk Factors of Hyperuricemia in Chinese Children and Adolescents: A Meta-Analysis
Abstract
Objective: To explore the prevalence and risk factors of hyperuricemia in Chinese children and adolescents by meta-analysis.
Material and Methods: The China National Knowledge Infrastructure (CNKI), Wanfang Data Knowledge Service platform, VIP Periodical Chinese Journal Service platform, PubMed, Embase database, Chinese BioMedical Literature database (CBM), Cochrane Library, Web of Science, and a manual search were all included in the extensive search, which had a final search date of September 2024. The meta-analysis was conducted using RevMan 5.4 and Stata 17.0.
Results: A total of 14 pieces of literature comprising 89359 patients were included. According to our review, the common risk factors reported were gender (male), age, overweight or obesity, hypertension, impaired glucose regulation, dyslipidemia, total cholesterol, triglycerides, low-density lipoprotein, high-density lipoprotein, and urea nitrogen were the key risk factors for hyperuricemia (HUA) in Chinese children and adolescents (p-value<0.05). In contrast, HUA in children and adolescents was not linked to a diet high in animal offal, waist circumference, or town residence (p-value>0.05).
Conclusion: The high rate of hyperuricemia in Chinese children and adolescents serves as a reminder to the general public, medical professionals, and those who determine health policy to get ready for the challenges that lie ahead.
Keywords
Full Text:
PDFReferences
Dincer HE, Dincer AP, Levinson DJ. Asymptomatic hyperuricemia: to treat or not to treat. Cleve Clin J Med 2002;69:594, 597, 600-2 passim.
Li Y, Shen Z, Zhu B, Zhang H, Zhang X, Ding X. Demographic, regional and temporal trends of hyperuricemia epidemics in mainland China from 2000 to 2019: a systematic review and meta-analysis. Glob Health Action 2021;14:1874652.
Wang shihan, YUan T. Risk factors, etiology, diagnosis and treatment of hyperuricemia and gout in children and adolescents. Chin J Clin Nutr 2021;29:163–70.
Rao J, Ye P, Lu J, Chen B, Li N, Zhang H, et al. Prevalence and related factors of hyperuricaemia in Chinese children and adolescents: a pooled analysis of 11 population-based studies. Ann Med 2022;54:1608–15.
Guo X, Xiao N, Jing X, Zhu Z, Zhang H. Analysis of the prevalence and influencing factors of hyperuricemia in children and adolescents aged 6–17 years in northeastern Sichuan Province. Chin J Child Health Care 2023;99:604–9.
Li L, Zhang Y, Zeng C. Update on the epidemiology, genetics, and therapeutic options of hyperuricemia. Am J Transl Res 2020;12:3167–81.
Guo K, Han Y, Liu S, Sun H, Lin X, Yang S, et al. Prevalence of and trends in hyperuricemia by race and ethnicity among US adolescents, 1999–2018. Arthritis Res Ther 2024;26:193.
Liu R, Han C, Wu D, Xia X, Gu J, Guan H, et al. Prevalence of Hyperuricemia and Gout in Mainland China from 2000 to 2014: a systematic review and meta-analysis. Biomed Res Int 2015;2015:762820.
Zhang M, Zhu X, Wu J, Huang Z, Zhao Z, Zhang X, et al. Prevalence of Hyperuricemia among Chinese adults: findings from two nationally representative cross-sectional surveys in 2015-16 and 2018-19. Front Immunol 2021;12:791983.
Nagahama K, Iseki K, Inoue T, Touma T, Ikemiya Y, Takishita S. Hyperuricemia and cardiovascular risk factor clustering in a screened cohort in Okinawa, Japan. Hypertens Res 2004;27:227–33.
Chuang SY, Lee SC, Hsieh YT, Pan WH. Trends in hyperuricemia and gout prevalence: Nutrition and Health Survey in Taiwan from 1993-1996 to 2005-2008. Asia Pac J Clin Nutr 2011;20:301–8.
Lohsoonthorn V, Dhanamun B, Williams MA. Prevalence of hyperuricemia and its relationship with metabolic syndrome in Thai adults receiving annual health exams. Arch Med Res 2006;37:883–9.
rong Wang, zhe Tang, fei Tang. Prevalence of hyperuricemia in the elderly in 7 areas of China. Chin J Epidemiol 2018;39:286–8.
Ou G, Wu J, Wang S, Jiang Y, Chen Y, Kong J, et al. Dietary factors and risk of Gout: a two-sample mendelian randomization study. Foods 2024;13:1269.
Shan R, Ning Y, Ma Y, Gao X, Zhou Z, Jin C, et al. Incidence and risk factors of Hyperuricemia among 2.5 million Chinese adults during the years 2017-2018. Int J Environ Res Public Health 2021;18:2360.
Li N, Zhang S, Li W, Wang L, Liu H, Li W, et al. Prevalence of hyperuricemia and its related risk factors among preschool children from China. Sci Rep 2017;7:9448.
Dai C, Wang C, Xia F, Liu Z, Mo Y, Shan X, et al. Age and gender-specific reference intervals for uric acid level in children aged 5-14 years in southeast zhejiang province of China: Hyperuricemia in children may need redefinition. Front Pediatr 2021;9:560720.
Moulin-Mares SRA, Zaniqueli D, Oliosa PR, Alvim RO, Bottoni JP, Mill JG. Uric acid reference values: report on 1750 healthy Brazilian children and adolescents. Pediatr Res 2021;89:1855–60.
Huang S, Hu Q, Li Z, Li Y, Zhao X, Shang Y, et al. Uric acid reference values for children and adolescents should be stratified by pubertal stage. Nutr Metab Cardiovasc Dis 2024;34:2757–62.
Kurahashi H, Watanabe M, Sugimoto M, Ariyoshi Y, Mahmood S, Araki M, et al. Testosterone replacement elevates the serum uric acid levels in patients with female to male gender identity disorder. Endocr J 2013;60:1321–7.
Abdullah AR, Hasan HA, Raigangar VL. Analysis of the relationship of leptin, high-sensitivity C-reactive protein, adiponectin, insulin, and uric acid to metabolic syndrome in lean, overweight, and obese young females. Metab Syndr Relat Disord 2009;7:17–22.
Ishizaka N, Ishizaka Y, Toda A, Tani M, Koike K, Yamakado M, et al. Changes in waist circumference and body mass index in relation to changes in serum uric acid in Japanese individuals. J Rheumatol 2010;37:410–6.
Jørgensen RM, Bøttger B, Vestergaard ET, Kremke B, Bahnsen RF, Nielsen BW, et al. Uric acid is elevated in children with obesity and decreases after weight loss. Front Pediatr 2021;9:814166.
Muntner P, Srinivasan S, Menke A, Patel DA, Chen W, Berenson G. Impact of childhood metabolic syndrome components on the risk of elevated uric acid in adulthood: the Bogalusa Heart Study. Am J Med Sci 2008;335:332–7.
Viazzi F, Rebora P, Giussani M, Orlando A, Stella A, Antolini L, et al. Increased serum uric acid levels blunt the antihypertensive efficacy of lifestyle modifications in children at cardiovascular risk. Hypertension 2016;67:934–40.
Niu Y, Zhao XL, Ruan HJ, Mao XM, Tang QY. Uric acid is associated with adiposity factors, especially with fat mass reduction during weight loss in obese children and adolescents. Nutr Metab (Lond) 2020;17:79.
Lurbe E, Torro MI, Alvarez-Pitti J, Redon J, Borghi C, Redon P. Uric acid is linked to cardiometabolic risk factors in overweight and obese youths. J Hypertens 2018;36:1840–6.
Zhang S, Zhang Y, Lin S, Zhang S, Qiu M. Hyperuricemia as a possible risk factor for abnormal lipid metabolism in the Chinese population: a cross-sectional study. Ann Palliat Med 2021;10:11454–63.
LIU D, SONG H qing, WANG X qin. Blood uric acid level and glucolipid metabolism characteristics in obese children. Medical Recapitulate 2016;22:2621–3.
Villegas R, Xiang YB, Elasy T, Xu WH, Cai H, Cai Q, et al. Purine-rich foods, protein intake, and the prevalence of hyperuricemia: the Shanghai Men’s Health Study. Nutr Metab Cardiovasc Dis 2012;22:409–16.
Reis LN, Renner JDP, Reuter CP, Horta JA, Paiva DN, Valim AR de M, et al. Hyperuricemia is associated with low cardiorespiratory fitness levels and excess weight in schoolchildren. J Pediatr (Rio J) 2017;93:538–43.
Fang Y, Tavengana G, Wu H, Mei W, Jiang C, Wang C, et al. Elevated blood pressure and hyperuricemia risk: a retrospective cohort study from Wuhu, China. Sci Rep 2024;14:19994.
Zhang Y, Zhang M, Yu X, Wei F, Chen C, Zhang K, et al. Association of hypertension and hypertriglyceridemia on incident hyperuricemia: an 8-year prospective cohort study. J Transl Med 2020;18:409.
Yin Y, Zhou E, Wu J. Association between hyperuricemia and long-term mortality in patients with hypertension: results from the NHANES 2001-2018. Front Cardiovasc Med 2024;11:1306026.
Vareldzis R, Perez A, Reisin E. Hyperuricemia: an intriguing connection to metabolic syndrome, diabetes, kidney disease, and hypertension. Curr Hypertens Rep 2024;26:237–45.
Bardin T, Richette P. Impact of comorbidities on gout and hyperuricaemia: an update on prevalence and treatment options. BMC Med 2017;15:123.
Borghi C, Piani F. Uric acid and estimate of renal function. Let’s stick together. Int J Cardiol 2020;310:157–8.
Fathallah-Shaykh SA, Cramer MT. Uric acid and the kidney. Pediatr Nephrol 2014;29:999–1008.
Jia Z, Zhang X, Kang S, Wu Y. Serum uric acid levels and incidence of impaired fasting glucose and type 2 diabetes mellitus: a meta-analysis of cohort studies. Diabetes Res Clin Pract 2013;101:88–96.
yingjuan Che, yan Chen, tingting Chen. Effect of high fat,high fat and high fructose diet on hyperuricemia in rats. Food & Machinery 2024;40:126–31.
Refbacks
- There are currently no refbacks.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.